Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Paulette Negron Ericksen's publication output changed over time?
ScholarIQpublication output · 2021–2025
Output grew0% over the shown period — from 1 works in 2021 to 1 in 2025.
1
1
2
1
2021202220242025
What are the most-cited papers on Paulette Negron Ericksen?
ScholarIQmost cited works
Standardization of coding definitions for sickle cell disease complications: A systematic literature review
Paulette Negron Ericksen, Firas Dabbous, Rajrupa Ghosh, Surbhi Shah, Xunming Sun, Emily Riehm Meier, Carmine Colavecchia
S140231191. 20242 CitationsOPEN ACCESS
Clinical and economic burden of achondroplasia in the United States: results from a retrospective, observational study
Nadia Merchant, José Alvir, Paulette Negron Ericksen, Jane Loftus, José Cara, Alison Slade, Michael P. Wajnrajch, Christine L. Baker
Orphanet Journal of Rare Diseases. 20251 CitationsOPEN ACCESS
Unplanned 30-Day Readmission Rates for Autosomal Dominant Polycystic Kidney Disease: Insight from the Nationwide Readmissions Database
Aparna Saha, Paulette Negron Ericksen, Cristina Liriano Cepin, Girish N. Nadkarni, Lili Chan
Blood Purification. 20220 CitationsOPEN ACCESS
Standardization of Coding Definitions for Sickle Cell Disease Complications: A Systematic Literature Review
Paulette Negron Ericksen, Firas Dabbous, Rajrupa Ghosh, Surbhi Shah, Xunming Sun, Emily Riehm Meier, Carmine Colavecchia
20240 CitationsOPEN ACCESS
Risk of 30-Day Hospital Readmission in Patients with ESKD with and Without Autosomal Dominant Polycystic Kidney Disease
Aparna Saha, Paulette Negron Ericksen, Cristina M. Liriano Cepin, Steven G. Coca, Girish N. Nadkarni, Lili Chan
Journal of the American Society of Nephrology. 20210 Citations
Related on ScholarIQ
Pfizer (United States)
Institution
Standardization of coding definitions for sickle cell disease complications: A systematic literature review
Paper
Clinical and economic burden of achondroplasia in the United States: results from a retrospective, observational study
Paper
Unplanned 30-Day Readmission Rates for Autosomal Dominant Polycystic Kidney Disease: Insight from the Nationwide Readmissions Database
Paper
Standardization of Coding Definitions for Sickle Cell Disease Complications: A Systematic Literature Review
Paper
Risk of 30-Day Hospital Readmission in Patients with ESKD with and Without Autosomal Dominant Polycystic Kidney Disease
Paper